Investigation of the roles of exosomes in colorectal cancer liver metastasis

Oncology Reports

Volumn 33, Issue 5, 2015, Pages 2445-2453

  Wang, Xia ^a   Ding, Xiaoling ^a   Nan, Lijuan ^a   Wang, Yiting ^a   Wang, Jing ^a   Yan, Zhiqiang ^a   Zhang, Wei ^a   Sun, Jihong ^b   Zhu, Wei ^c   Ni, Bing ^a   Dong, Suzhen ^a   Yu, Lei ^a  

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Colorectal cancer; CXCR4; Exosomes; Liver metastasis; Migration

Indexed keywords

CD63 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; HEAT SHOCK PROTEIN 70;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CACO 2 CELL LINE; CANCER GROWTH; CELL FUNCTION; CELL MIGRATION; CELL VACUOLE; COLORECTAL CANCER; CONTROLLED STUDY; ELECTRON MICROSCOPY; EXOSOME; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HT 29 CELL LINE; IN VITRO STUDY; LIVER METASTASIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; TUMOR MICROENVIRONMENT; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; COLORECTAL TUMOR; HUMAN; LIVER TUMOR; METABOLISM; METASTASIS; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; SECONDARY; TUMOR CELL LINE;

ANIMALS; CACO-2 CELLS; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; EXOSOMES; HT29 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM METASTASIS; RECEPTORS, CXCR4; TUMOR MICROENVIRONMENT;

EID: 84927144443     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.3843     Document Type: Article

References (54)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61:69-90, 2011.
2. Pancione M, Giordano G, Remo A, et al: Immune escape mechanisms in colorectal cancer pathogenesis and liver metastasis. J Immunol Res 2014:11, 2014.
3. Alderton GK: Metastasis. Exosomes drive premetastatic niche formation. Nat Rev Cancer 12:447, 2012.
4. Peinado H, Aleckovic M, Lavotshkin S, et al: Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 18:883-891, 2012.
5. Kosaka N, Iguchi H, Hagiwara K, Yoshioka Y, Takeshita F and Ochiya T: Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis. J Biol Chem 288:10849-10859, 2013.
6. Thery C, Ostrowski M and Segura E: Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 9:581-593, 2009.
7. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ and Lotvall JO: Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654-659, 2007.
8. Bang C and Thum T: Exosomes: new players in cell-cell communication. Int J Biochem Cell Biol 44:2060-2064, 2012.
9. Raposo G, Nijman HW, Stoorvogel W, et al: B lymphocytes secrete antigen-presenting vesicles. J Exp Med 183:1161-1172, 1996.
10. Lima LG, Chammas R, Monteiro RQ, Moreira ME and Barcinski MA: Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserinedependent manner. Cancer Lett 283:168-175, 2009.
11. Hood JL, San RS and Wickline SA: Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res 71:3792-3801, 2011.
12. Skog J, Wurdinger T, van Rijn S, et al: Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10:1470-1476, 2008.
13. Jung T, Castellana D, Klingbeil P, et al: CD44v6 dependence of premetastatic niche preparation by exosomes. Neoplasia 11:1093-1105, 2009.
14. Azmi AS, Bao B and Sarkar FH: Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev 32:623-642, 2013.
15. Vlassov AV, Magdaleno S, Setterquist R and Conrad R: Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta 1820:940-948, 2012.
16. Liu Y, Xiang X, Zhuang X, et al: Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells. Am J Pathol 176:2490-2499, 2010.
17. Hood JL, Pan H, Lanza GM and Wickline SA: Paracrine induction of endothelium by tumor exosomes. Lab Invest 89:1317-1328, 2009.
18. Silva J, Garcia V, Rodriguez M, et al: Analysis of exosome release and its prognostic value in human colorectal cancer. Genes Chromosomes Cancer 51:409-418, 2012.
19. Hong B, Cho JH, Kim H, et al: Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells. BMC Genomics 10:556, 2009.
20. Choi DS, Lee JM, Park GW, et al: Proteomic analysis of microvesicles derived from human colorectal cancer cells. J Proteome Res 6:4646-4655, 2007.
21. Mathivanan S, Lim JW, Tauro BJ, Ji H, Moritz RL and Simpson RJ: Proteomics analysis of A33 immunoaffinitypurified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Mol Cell Proteomics 9:197-208, 2010.
22. Choi DS, Park JO, Jang SC, et al: Proteomic analysis of microvesicles derived from human colorectal cancer ascites. Proteomics 11:2745-2751, 2011.
23. Demory Beckler M, Higginbotham JN, Franklin JL, et al: Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. Mol Cell Proteomics 12:343-355, 2012.
24. Choi DS, Choi DY, Hong BS, et al: Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells. J Extracell Vesicles 1:18704, 2012. doi: http://dx.doi.org/10.3402/jev. v1i0.18704.
25. Ji H, Greening DW, Barnes TW, et al: Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components. Proteomics 13:1672-1686, 2013.
26. Nicolson GL: Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis. Cancer Metastasis Rev 12:325-343, 1993.
27. Fidler IJ: The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3:453-458, 2003.
28. Joukov V, Pajusola K, Kaipainen A, et al: A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. Embo j 15:1751, 1996.
29. Achen MG, Jeltsch M, Kukk E, et al: Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 95:548-553, 1998.
30. Youngs SJ, Ali SA, Taub DD and Rees RC: Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer 71:257-266, 1997.
31. Kim H and Muller WJ: The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis. Exp Cell Res 253:78-87, 1999.
32. Muller A, Homey B, Soto H, et al: Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50-56, 2001.
33. Zeelenberg IS, Ruuls-Van Stalle L and Roos E: Retention of CXCR4 in the endoplasmic reticulum blocks dissemination of a T cell hybridoma. J Clin Invest 108:269-277, 2001.
34. Kitaori T, Ito H, Schwarz EM, et al: Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum 60:813-823, 2009.
35. Dewan MZ, Ahmed S, Iwasaki Y, Ohba K, Toi M and Yamamoto N: Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer. Biomed Pharmacother 60:273-276, 2006.
36. Yasumoto K, Koizumi K, Kawashima A, et al: Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Res 66:2181-2187, 2006.
37. Kucia M, Reca R, Miekus K, et al: Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 23:879-894, 2005.
38. El-Andaloussi S, Lee Y, Lakhal-Littleton S, et al: Exosomemediated delivery of siRNA in vitro and in vivo. Nat Protoc 7:2112-2126, 2012.
39. null (NOG) mice. Int J Oncol 32:153-159, 2008.
40. Voisin T, El Firar A, Fasseu M, et al: Aberrant expression of OX1 receptors for orexins in colon cancers and liver metastases: an openable gate to apoptosis. Cancer Res 71:3341-3351, 2011.
41. Moreno A, López LA, Fabra A and Arús C: 1H MRS markers of tumour growth in intrasplenic tumours and liver metastasis induced by injection of HT-29 cells in nude mice spleen. NMR Biomed 11:93-106, 1998.
42. Van Niel G, Raposo G, Candalh C, et al: Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology 121:337-349, 2001.
43. Suetsugu A, Honma K, Saji S, Moriwaki H, Ochiya T and Hoffman RM: Imaging exosome transfer from breast cancer cells to stroma at metastatic sites in orthotopic nude-mouse models. Adv Drug Deliv Rev 65:383-390, 2013.
44. Nazarenko I, Rana S, Baumann A, et al: Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Cancer Res 70:1668-1678, 2010.
45. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A and Ratajczak MZ: Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20:1487-1495, 2006.
46. Fidler IJ: Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of metastasis. Cancer Metastasis Rev 10:229-243, 1991.
47. Giavazzi R, Campbell DE, Jessup JM, Cleary K and Fidler IJ: Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice. cancer res 46:1928-1933, 1986.
48. Balaj L, Lessard R, Dai L, et al: Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat Commun 2:180, 2011.
49. Aliotta JM, Pereira M, Johnson KW, et al: Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcription. Exp Hematol 38:233-245, 2010.
50. Aliotta JM, Sanchez-Guijo FM, Dooner GJ, et al: Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation. Stem Cells 25:2245-2256, 2007.
51. Grange C, Tapparo M, Collino F, et al: Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res 71:5346-5356, 2011.
52. Zeelenberg IS, Ruuls-Van Stalle L and Roos E: The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res 63:3833-3839, 2003.
53. Tamamura H, Hori A, Kanzaki N, et al: T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer. FEBS Lett 550:79-83, 2003.
54. Bertolini F, Dell'Agnola C, Mancuso P, et al: CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma. Cancer Res 62:3106-3112, 2002.